HUP0001286A3 - Pharmaceutical composition containing carbazole acetic acid for treating pain and inflammation in dogs - Google Patents

Pharmaceutical composition containing carbazole acetic acid for treating pain and inflammation in dogs

Info

Publication number
HUP0001286A3
HUP0001286A3 HU0001286A HUP0001286A HUP0001286A3 HU P0001286 A3 HUP0001286 A3 HU P0001286A3 HU 0001286 A HU0001286 A HU 0001286A HU P0001286 A HUP0001286 A HU P0001286A HU P0001286 A3 HUP0001286 A3 HU P0001286A3
Authority
HU
Hungary
Prior art keywords
dogs
inflammation
pharmaceutical composition
acetic acid
composition containing
Prior art date
Application number
HU0001286A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HUP0001286A2 publication Critical patent/HUP0001286A2/hu
Publication of HUP0001286A3 publication Critical patent/HUP0001286A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
HU0001286A 1997-05-05 1998-05-01 Pharmaceutical composition containing carbazole acetic acid for treating pain and inflammation in dogs HUP0001286A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05
PCT/IB1998/000662 WO1998050033A1 (en) 1997-05-05 1998-05-01 Cox-2 selective carprofen for treating pain and inflammation in dogs

Publications (2)

Publication Number Publication Date
HUP0001286A2 HUP0001286A2 (hu) 2000-11-28
HUP0001286A3 true HUP0001286A3 (en) 2000-12-28

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001286A HUP0001286A3 (en) 1997-05-05 1998-05-01 Pharmaceutical composition containing carbazole acetic acid for treating pain and inflammation in dogs

Country Status (32)

Country Link
EP (1) EP0988034A1 (is)
JP (1) JP2000513020A (is)
KR (2) KR20040004406A (is)
CN (1) CN1255059A (is)
AP (1) AP9801234A0 (is)
AR (2) AR011726A1 (is)
AU (1) AU6932198A (is)
BG (1) BG103852A (is)
BR (1) BR9808720A (is)
CA (1) CA2288759A1 (is)
DZ (1) DZ2479A1 (is)
EA (1) EA003696B1 (is)
GT (1) GT199800063A (is)
HR (1) HRP980244A2 (is)
HU (1) HUP0001286A3 (is)
ID (1) ID21311A (is)
IL (1) IL132570A0 (is)
IS (1) IS5220A (is)
MA (1) MA26491A1 (is)
NO (1) NO995389L (is)
NZ (1) NZ500183A (is)
OA (1) OA11213A (is)
PA (1) PA8450601A1 (is)
PE (1) PE72599A1 (is)
PL (1) PL337003A1 (is)
SK (1) SK148199A3 (is)
TN (1) TNSN98059A1 (is)
TW (1) TW590773B (is)
UY (1) UY24989A1 (is)
WO (1) WO1998050033A1 (is)
YU (1) YU55899A (is)
ZA (1) ZA983722B (is)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
AU764872B2 (en) * 1998-10-23 2003-09-04 Merck Frosst Canada & Co. Combination product comprising an E-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
ATE306263T1 (de) * 1999-03-10 2005-10-15 Searle Llc Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere
AU1592901A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
AU2001259974A1 (en) * 2000-05-15 2001-11-26 Merck Frosst Canada & Co Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
IL153303A0 (en) 2000-06-13 2003-07-06 Wyeth Corp Analgesic and anti-inflammatory compositions conaining cox-2 inhibitors
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
ATE420201T1 (de) 2000-08-07 2009-01-15 Univ Vanderbilt Nachweis der cox-2 aktivität und von anandamid- metaboliten
AU2002354901A1 (en) * 2001-07-16 2003-03-03 Edward Hogestatt Compounds with analgesic, antipyretic and/or anti-inflammatory activity
EP1745791B1 (en) 2003-05-07 2013-06-26 Osteologix A/S Treating cartilage/bone conditions with water-soluble strontium salts
RU2319508C2 (ru) * 2003-07-31 2008-03-20 ФАРМАЦИЯ ЭНД АПДЖОН КОМПАНИ ЭлЭлСи Диспергируемый препарат противовоспалительного агента
AU2006248645A1 (en) * 2005-05-20 2006-11-23 Pfizer Limited Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands
EP2079456B1 (en) 2007-04-04 2012-12-05 Sigmoid Pharma Limited Pharmaceutical cyclosporin compositions
EP2586428B1 (en) 2007-04-26 2023-11-08 Sublimity Therapeutics Limited Manufacture of multiple minicapsules
ES2649112T3 (es) 2009-05-18 2018-01-10 Sigmoid Pharma Limited Composición que comprende gotas de aceite
CN107582526A (zh) 2009-08-12 2018-01-16 希格默伊德药业有限公司 包含聚合物基质和油相的免疫调节组合物
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
JP6419857B2 (ja) * 2014-03-06 2018-11-07 アラタナ セラピューティクス、 インコーポレイテッド グラピプラント組成物およびその使用方法
US12109218B2 (en) 2014-12-09 2024-10-08 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
EP3881829A1 (en) 2014-11-07 2021-09-22 Sublimity Therapeutics Limited Compositions comprising cyclosporin
US20180264061A1 (en) * 2015-01-09 2018-09-20 Jaguar Animal Health Methods of Treating Diarrhea in Companion Animals
EP4125874A4 (en) * 2020-03-25 2024-05-01 SRI International LIPOXYGENASE INHIBITORS
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions

Also Published As

Publication number Publication date
BG103852A (en) 2000-06-30
DZ2479A1 (fr) 2003-02-01
EA199900895A1 (ru) 2000-06-26
HUP0001286A2 (hu) 2000-11-28
EP0988034A1 (en) 2000-03-29
AP9801234A0 (en) 1999-11-04
PE72599A1 (es) 1999-08-12
HRP980244A2 (en) 1999-02-28
PL337003A1 (en) 2000-07-31
NO995389D0 (no) 1999-11-04
AR039628A2 (es) 2005-03-02
TNSN98059A1 (fr) 2005-03-15
ZA983722B (en) 1999-11-04
NZ500183A (en) 2002-04-26
NO995389L (no) 2000-01-04
BR9808720A (pt) 2000-07-11
AR011726A1 (es) 2000-08-30
CA2288759A1 (en) 1998-11-12
PA8450601A1 (es) 2000-05-24
MA26491A1 (fr) 2004-12-20
IS5220A (is) 1999-10-19
GT199800063A (es) 1999-10-26
WO1998050033A1 (en) 1998-11-12
IL132570A0 (en) 2001-03-19
JP2000513020A (ja) 2000-10-03
YU55899A (sh) 2003-08-29
SK148199A3 (en) 2001-09-11
KR20010012300A (ko) 2001-02-15
EA003696B1 (ru) 2003-08-28
TW590773B (en) 2004-06-11
KR20040004406A (ko) 2004-01-13
CN1255059A (zh) 2000-05-31
OA11213A (en) 2003-07-14
UY24989A1 (es) 2001-10-25
AU6932198A (en) 1998-11-27
ID21311A (id) 1999-05-20

Similar Documents

Publication Publication Date Title
HUP0001286A3 (en) Pharmaceutical composition containing carbazole acetic acid for treating pain and inflammation in dogs
IL128600A0 (en) Propionic acid derivatives and pharmaceutical compositions containing them
EP0858334A4 (en) IMMEDIATE AND SLOW RELEASE ANALGESIC PHARMACEUTICAL COMPOSITION
HUP0004170A3 (en) Methods and materials for treating and preventing inflammation ofmucosal tissue
HUP0202338A3 (en) Pharmaceutical composition containing fenofibrate and preparation method
AU1534899A (en) Device and method for non-occlusive localized drug delivery
HUP0100178A3 (en) Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof
CY2424B1 (en) Pharmaceutical composition for use in treatment ofdiabetes.
GB2331247B (en) Improvements in relation to apparatus for surgical diathermy
IL144872A0 (en) Gabapentin derivative for preventing and treating visceral pain
AU7696098A (en) Substance p inhibitors in combination with nmda-blockers for treating pain
PL344246A1 (en) Novel pharmaceutical composition for use in emergency treatment and preparation method thereof
IL133784A (en) Dolastatin 15 derivatives, pharmaceutical compositions comprising them and their use in medicaments for treating cancer
AU4224600A (en) Composition and method for treatment of inflammation and pain in mammals
AU2027695A (en) Pharmaceutical composition for treating stoma-peripheral inflammation diseases
IL131229A0 (en) Compounds and methods for therapeutic intervention in preventing diabetic complications
SI0864559T1 (en) Substituted amino compounds and their use as analgesic active substances
ZA922017B (en) Methods and substances for recruiting therapeutic agents to solid tissues
HUP0004223A3 (en) 4-oxo-butynic acids and pharmaceutical composition containing them as active agent
IL131666A0 (en) Novel carboxylic acid derivatives their preparation and use in treating cancer
NO20000371L (no) Aminoetylfenoksyeddiksyrederivater og legemidler for smertereduksjon og kalksteinfjerningsfremming i urin litiasis
AU7793791A (en) Pharmaceutical composition for use in treating pain
AU2587195A (en) Growth hormone therapy and related methods and pharmaceutical compositions
AU1026399A (en) Pharmaceutical compositions containing ricinoleic acid and their use in anti-inflammatory and analgesic therapy
SG65766A1 (en) Composition for preventing and treating gingival diseases